Page last updated: 2024-10-23

atenolol and Chagas Cardiomyopathy

atenolol has been researched along with Chagas Cardiomyopathy in 2 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Chagas Cardiomyopathy: A disease of the CARDIAC MUSCLE developed subsequent to the initial protozoan infection by TRYPANOSOMA CRUZI. After infection, less than 10% develop acute illness such as MYOCARDITIS (mostly in children). The disease then enters a latent phase without clinical symptoms until about 20 years later. Myocardial symptoms of advanced CHAGAS DISEASE include conduction defects (HEART BLOCK) and CARDIOMEGALY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Medei, EH1
Nascimento, JH1
Pedrosa, RC1
Barcellos, L1
Masuda, MO1
Sicouri, S1
Elizari, MV1
de Carvalho, AC1
Sterin-Borda, L1
Gorelik, G1
Postan, M1
Gonzalez Cappa, S1
Borda, E1

Other Studies

2 other studies available for atenolol and Chagas Cardiomyopathy

ArticleYear
Antibodies with beta-adrenergic activity from chronic chagasic patients modulate the QT interval and M cell action potential duration.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2008, Volume: 10, Issue:7

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atenolol; Calcium Channels, L-Type; Chagas Cardi

2008
Alterations in cardiac beta-adrenergic receptors in chagasic mice and their association with circulating beta-adrenoceptor-related autoantibodies.
    Cardiovascular research, 1999, Volume: 41, Issue:1

    Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Atenolol; Autoantibodies; Chagas Cardiom

1999